An enhanced international prognostic index (IPI) for patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era using the National Comprehensive Cancer Network (NCCN) database Meeting Abstract


Authors: Zhou, Z.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Vanderplas, A.; Crosby-Thompson, A.; Zelenetz, A. D.; Abel, G. A.; Rodriguez, M. A.; Nademanee, A.; Kaminski, M. S.; Czuczman, M. S.; Millenson, M.; Niland, J.; Friedberg, J. W.; Winter, J. N.
Abstract Title: An enhanced international prognostic index (IPI) for patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era using the National Comprehensive Cancer Network (NCCN) database
Meeting Title: 54th Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 120
Issue: 21
Meeting Dates: 2012 Dec 8-11
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2012-11-01
Language: English
ACCESSION: WOS:000313838903137
PROVIDER: wos
DOI: 10.1182/blood.V120.21.2656.2656
Notes: --- - Meeting Abstract: 2656 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz